Antagonistic activity against Helicobacter pylori infection in vitro by a strain of Enterococcus faecium TM39

International Journal of Food Microbiology

Volumn 96, Issue 1, 2004, Pages 1-12

  Tsai, Cheng Chih ^a   Huang, Li Fang ^a   Lin, Chia Chen ^a   Tsen, Hau Yang ^b  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^b HUNGKUANG UNIVERSITY   (Taiwan)

Author keywords

Adhesion; Enterococcus faecium; Helicobacter pylori; Urease

Indexed keywords

ACID; AMPICILLIN; BETA LACTAMASE; BILE SALT; CARBENICILLIN; CEFOTAXIME; CEFTRIAXONE; CHLORAMPHENICOL; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; KANAMYCIN; LACTIC ACID; LINCOMYCIN; METICILLIN; NEOMYCIN; OFLOXACIN; OXACILLIN; PENICILLIN G; PROBIOTIC AGENT; STREPTOMYCIN; TETRACYCLINE; TRIMETHOPRIM; UREASE; VANCOMYCIN;

ACID TOLERANCE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL CELL; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; CARCINOMA CELL; CELL ADHESION; CELL INTERACTION; CELL STRAIN CACO 2; CELL VIABILITY; CONTROLLED STUDY; DRUG SAFETY; ENTEROCOCCUS FAECIUM; ENZYME ACTIVITY; ENZYME INHIBITION; EVALUATION; FEEDING; GROWTH INHIBITION; HELA CELL; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; INTESTINE EPITHELIUM CELL; NONHUMAN; PH; SALT TOLERANCE; SPECIES INVASION; STOMACH CARCINOMA; SUPERNATANT;

ANIMALS; BACTERIAL ADHESION; CELL LINE; CELL LINE, TUMOR; CULTURE MEDIA; ENTEROCOCCUS FAECIUM; FECES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; HYDROGEN-ION CONCENTRATION; INFANT; MICROBIAL SENSITIVITY TESTS; PROBIOTICS; RATS; RATS, WISTAR; UREASE; VANCOMYCIN RESISTANCE;

ENTEROCOCCUS; ENTEROCOCCUS FAECIUM; HELICOBACTER; HELICOBACTER PYLORI; RATTUS NORVEGICUS;

EID: 4444376728     PISSN: 01681605     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijfoodmicro.2003.10.019     Document Type: Article

References (42)

1. Armuzzi A., Cremonini F., Bartolozzi F., Candelli M., Ojetti V., Cammarota G., Anti M., De Lorenzo A., Pola P., Gasbarrini G., Gasbarrini A. The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy. Alimentary Pharmacology and Therapeutics. 15:2001;163-169
2. Bernet M.F., Brassart D., Neeser J.R., Servin A.L. Lactobacillus acidophilus LA1 binds to cultured human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria. Gut. 35:1994;483-489
3. Bernet-Camard M.F., Lievin V., Brassart D., Neeser J.R., Servin A.L., Hudault S. The human Lactobacillus acidophilus LA1 secretes a nonbacteriocin antibacterial substance(s) active in vitro and in vivo. Applied and Environmental Microbiology. 63:1997;2747-2753
4. Blaser M.J. Helicobacter pylori: microbiology of a slow bacterial infection. Trends in Microbiology. 1:1993;255-260
5. Canducci F., Armuzzi A., Cremonini F., Cammarota G., Bartolozzi F., Pola P., Gasbarrini G., Gasbarrini A. A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates. Alimentary Pharmacology and Therapeutics. 14:2000;1625-1629
6. Clyne M., Labigne A., Drumm B. Helicobacter pylori requires an acidic environment to survive in the presence of urea. Infection and Immunity. 63:1995;1669-1673
7. Coconnier M.H., Lievin V., Hemery E., Servin A. Antagonistic activity against Helicobacter infection in vitro and in vivo by the human Lactobacillus acidophilus strain LB. Applied and Environmental Microbiology. 64:1998;4573-4580
8. Conway P.L., Gorbach S.L., Goldin B.R. Survival of lactic acid bacteria in the human stomach and adhesion to intestinal cells. Journal of Dairy Science. 70:1987;1-12
9. Donohue D., Deighton M., Ahokas J.T., Salminen S. Toxicity of lactic acid bacteria. Salminen S., von Wright A. Lactic Acid Bacteria. 1993;307-313 Marcel Dekker, New York
10. Dunn B.E., Cohen H., Blaser M.J. Helicobacter pylori. Clinical Microbiology Reviews. 10:1997;720-741
11. FAO/WHO Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. Report of a Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria. Cördoba, Argentina, 1-4 October 2001. 2001;FAO/WHO, Rome, Italy and Geneva, Switzerland
12. Ford H.R., Avanoglu A., Boechat P.R., Melgoza R., Lum-Cheong R.S., Boyle P., Garrett M., Rowe M.I. The microenvironment influences the pattern of bacterial translocation in formula-fed neonates. Journal of Pediatric Surgery. 31:1996;486-489
13. Franz C.M.A.P., Schillinger U., Holzapfel W.H. Production and characterization of enterocin 900, a bacteriocin produced by Enterococcus faecium BFE 900 from black olives. International Journal of Food Microbiology. 29:1996;225-270
14. Franz C.M.A.P., Holzapfel W.H., Stiles M.E. Enterococci at the crossroads of food safety? International Journal of Food Microbiology. 47:1999;1-24
15. Franz C.M.A.P., Albrecht B., Muscholl-Silberhorn N.M.K., Yousif M.V., Jean S., Wilhelm H.H. Incidence of virulence factors and antibiotic resistance among Enterococci isolated from food. Applied and Environmental Microbiology. 67:2001;4385-4389
16. Fris-Møller A., Hey H. Colonization of the intestinal canal with a Streptococcus faecium preparation (Paraghurt). Current Therapeutic Research. 33:1983;807-815
17. Fuller R. Probiotics in human medicine. Gut. 32:1991;439-442
18. Gilliland S.E., Walker D.K. Factors to consider when selecting a dietary adjunct to produce a hypocholesteroleric effect in humans. Journal of Dairy Science. 73:1990;905-911
19. Giraffa G., Pepe G., Locci F., Neviani E., Carminati D. Hemolytic activity, production of thermonuclease and biogenic amines by dairy enterococci Italy. Journal of Food Microbiology. 64:1995;105-117
20. Gopal P.K., Prasad J., Smart J., Gill H.S. In vitro adherence properties of Lactobacillus rhamnosus DR20 and Bifidobacterium lactis DR10 strains and their antagonistic activity against an enterotoxigenic Escherichia coli. International Journal of Food Microbiology. 67:2001;207-216
21. Huis in't Veld J.H.J., Havenaar R., Marteau P. Establishing a scientific basis for probiotic R&D. Trends in Biotechnology. 12:1994;6-8
22. Jacobsen C.N., Rosenfeldt Nielsen V., Hayford A.E., Møller P.L., Michaelsen K.F., Pærregaard A., Sandström B., Tvede M., Jakobsen M. Screening of probiotic activities of forty-seven strains of Lactobacillus spp. by in vitro techniques and evaluation of the colonization ability of five selected strains in humans. Applied and Environmental Microbiology. 65:1999;4949-4956
23. Kailasapathy K., Rybka S. L. acidophilus and Bifidobacterium spp. - their therapeutic potential and survival in yoghurt. Australian Journal of Dairy Technology. 52:1997;28-35
24. Lalonde M., Segura M., Lacouture S., Gottschalk M. Interactions between Streptococcus suis serotype 2 and different epithelial cell lines. Microbiology. 146:2000;1913-1921
25. Lehto E.M., Salminen S. Adhesion of two Lactobacillus strains, one Lactococcus and one Propionibacterium strain to cultured human intestinal Caco-2 cell line. Bioscience and Microflora. 16:1997;13-17
26. Lewenstein A., Frigerio G., Moroni M. Biological properties of SF, a new approach for the treatment of diarrheal diseases. Current Therapeutic Research. 26:1979;967-981
27. Michetti P., Dorta G., Brassart D., Vouillamoz D., Schwitzer W., Felley C., Blum A.L., Porta N., Rouvet M., Corthesy-Theulaz I. L. acidophilus supernatant as an adjuvant in the therapy of H. pylori in humans. Gastroenterology. 108:1995;A166
28. Midolo P.D., Lambert J.R., Hull R., Luo F., Grayson M.L. In vitro inhibition of Helicobacter pylori NCTC 11637 by organic acids and lactic acid bacteria. Journal of Applied Bacteriology. 79:1995;475-479
29. Nakamura H., Yoshiyama H., Takeuchi H., Mizote T., Okita K., Nakazawa T. Urease plays an important role in the chemotactic motility of Helicobacter pylori in a viscous environment. Infection and Immunity. 66:1998;4832-4837
30. National Committee for Clinical Laboratory Standards Performance standards for antimicrobial disk susceptibility tests. M2-A6. 6th edn.:1998;National Committee for Clinical Laboratory Standard, Villanova, PA
31. Parsonnet J., Vandersteen D., Goates J., Sibley R.K., Pritikin J., Chang Y. Helicobacter pylori infection in intestinal- and diffuse-type gastric adenocarcinomas. Journal of the National Cancer Institute. 83:1991;640-643
32. Perdigon G., Nader de Macias M.E., Alvarez S., Oliver G., Pesce de Ruiz Holgado A.A. Enhancement of immune response in mice fed with Streptococcus thermophilus and Lactobacillus acidophilus. Journal of Dairy Science. 70:1987;919-926
33. Rieder G., Hatz R.A., Moran A.P., Walz A., Stolte M., Enders G. Role of adherence in interleukin-8 induction in Helicobacter pylori-associated gastritis. Infection and Immunity. 65:1997;3622-3630
34. Rodricks J.V. Safety assessment of new food ingredients. Food Technology. 3:1996;1114-1117
35. Sakamoto I., Igarashi M., Kimura K., Takagi A., Miwa T., Koga Y. Suppressive effect of Lactobacillus gasseri OLL 2716 (LG21) on Helicobacter pylori infection in humans. Journal of Antimicrobial Chemotherapy. 47:2001;709-710
36. Sarem F., Darem-Damerdji L.O., Nicolas J.P. Comparison of the adherence of three Lactobacillus strains to Caco-2 and Int-407 human intestinal cell lines. Letter Applied Microbiology. 22:1996;439-442
37. Shyu R.Y., Jiang S.Y., Wang C.C., Wu M.F., Harn H.J., Chang T.M., Yeh M.Y. Establishment and characterization of TSGH9201, a human gastric carcinoma cell line that is growth inhibited by epidermal growth factor. Journal of Surgical Oncology. 58:1995;17-24
38. Stuart-Tilley A., Sardet C., Pouyssegur J., Schwartz M.A., Brown D., Alper S.L. Immunolocalization of anion exchanger AE2 and cation exchanger NHE-1 in distinct adjacent cells of gastric mucosa. American Journal of Physiology. 266:1994;C559-C568
39. Tang P., Foubister V., Pucciarelli M.G., Finlay B.B. Methods to study bacterial invasion. Journal of Microbiological Methods. 18:1993;227-240
40. Urao M., Teitelbaum D.H., Drongowski R.A., Coran A.G. The association of gut-associated lymphoid tissue and bacterial translocation in the newborn rabbit. Journal of Pediatric Surgery. 31:1996;1482-1487
41. Wadström T., Hirmo S., Novak H., Guzman A., Ringner-Pantzar M., Utt M., Aleljung P. Sulfatides inhibit binding of Helicobacter pylori to the gastric cancer Kato III cell line. Current Microbiology. 34:1997;267-272
42. Zavaglia A.G., Kociubinski G., Perez P., de Antoni G. Isolation and characterization of Bifidobacterium strains for probiotic formulation. Journal of Food Protection. 61:1998;865-873